hematology - imed 2017updateinternalmedicine.com/.../60-drews-hematology-review-(print)_new.pdf ·...

24
Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA COPYRIGHT

Upload: lekhanh

Post on 27-Aug-2019

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Hematology:Challenging Cases with

Your ParticipationReed E. Drews, MD

Beth Israel Deaconess Medical CenterHarvard Medical School

Boston, MA

COPYRIG

HT

Page 2: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 1COPYRIG

HT

Page 3: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 1

• 64-year-old man is evaluated during routine exam

• He takes aspirin and acetaminophen for osteoarthritis

• On exam, pallor is absent. BP = 116/72 with no orthostatic changes; P = 68.COP

YRIGHT

Page 4: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Labs

• Hgb = 9.7 g/dL• WBC = 5.8 K/μL• MCV = 83 fL• Plts = 265 K/μL• Retic count = 0.5%• LDH = 80 U/L• Iron = 40 μg/dL• TIBC = 200 μg/dL• Ferritin = 210 ng/mL• Peripheral smear is normal

COPYRIG

HT

Page 5: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Which of the following is the most likely diagnosis?

A. Inflammatory anemia

B. Hemoglobin C disease

C. Iron deficiency

D. Thalassemia

COPYRIG

HT

Page 6: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 2COPYRIG

HT

Page 7: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 2

• 27-year-old woman undergoes follow-up evaluation 5 months after diagnosis of unprovoked PE for which she was prescribed a 6-month course of anticoagulant therapy

• Family history– Maternal grandmother took warfarin for many years

for unknown reason

– Older brother with DVT at age 32 years

• Meds: no contraceptives or other medications

• Labs: CBC normal; INR = 3.0

COPYRIG

HT

Page 8: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Which of the following is the most appropriate next step in the evaluation of this patient?

A. Immediate thrombophilic screening

B. JAK2 mutation analysis

C. No further evaluation needed

D. Thrombophilic screening at least 2 weeks after therapy cessationCOP

YRIGHT

Page 9: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 3COPYRIG

HT

Page 10: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 3

• A 68-year old woman has hypertension for which she takes HCTZ and low-dose aspirin daily. On routine blood testing, she is found to have a high total protein.

• On exam, she appears well without lymphadenopathy, hepatosplenomegaly or bony pain to palpation or percussion.

• Hgb = 12.9 g/dL; WBC = 6.2K/μL; platelets = 245K/μL.

• SPEP shows 1.2 g/dL monoclonal IgG-kappa. UPEP is negative for protein, including Bence Jones protein.

COPYRIG

HT

Page 11: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 3 (continued)

Bone marrow biopsy shows 7% plasma cells, and skeletal survey is normal, without lytic lesions. Which is the most appropriate management for this patient?

1. Obtain a bone scan

2. Begin bisphosphonate therapy

3. Begin thalidomide + dexamethasone

4. Monitor expectantly and repeat the SPEP and UPEP in 3 to 6 months

COPYRIG

HT

Page 12: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 4

COPYRIG

HT

Page 13: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 4

• A 65-year old presents with cervical adenopathy and splenomegaly.

• HCT = 37%; WBC = 34,000/µL with 2% polys and 98% lymphs; platelets = 177,000/µL.

• Peripheral blood smear review reveals mature appearing lymphocytes and “smudge cells” (see next slide).

COPYRIG

HT

Page 14: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

COPYRIG

HT

Page 15: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 4 (continued)

Which of the following is true of this patient?

1. Patients in late childhood or young adulthood are as likely to have this disease as older patients

2. One should be alert for the “blast phase” of disease

3. The patient might present with autoimmune hemolytic anemia and/or immune thrombocytopenia

4. The evidence favors early treatment

COPYRIG

HT

Page 16: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 5COPYRIG

HT

Page 17: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 5

• A 63-year old patient develops exertional dyspnea.

• On exam, sclerae are slightly icteric.

• HCT = 28% with MCV = 105; reticulocyte count = 9%; WBC and platelet counts are normal.

• The laboratory reports “bite” cells on peripheral blood smear (see next slide).

COPYRIG

HT

Page 18: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

COPYRIG

HT

Page 19: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 5 (continued)

What is the most likely underlying mechanism of anemia in this patient?

1. Autoimmune hemolysis

2. Microangiopathic hemolytic anemia

3. Oxidant hemolysis

4. Paroxysmal nocturnal hemoglobinuria

COPYRIG

HT

Page 20: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 6COPYRIG

HT

Page 21: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 6

• A 24-year old patient develops dyspnea and is found to be anemic with HCT = 28%, MCV = 104 fL, and reticulocyte count = 6%.

• The laboratory reports 2+ spherocytes on peripheral blood smear (see next slide).COP

YRIGHT

Page 22: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

COPYRIG

HT

Page 23: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

Question 6 (continued)

Coombs testing is positive for IgG and negative for C3. What is the most appropriate management in this patient?

1. Transfuse packed red blood cells

2. Begin prednisone 1 mg/kg and folic acid 5 mg daily

3. Begin danazol

4. Administer rituximab

COPYRIG

HT

Page 24: Hematology - IMED 2017updateinternalmedicine.com/.../60-Drews-Hematology-Review-(print)_new.pdf · Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel

The End

COPYRIG

HT